Analysts Set Masimo Corporation (NASDAQ:MASI) Target Price at $180.40

Shares of Masimo Corporation (NASDAQ:MASI – Get Free Report) have received a consensus rating of “Hold” from the nine analysts that are covering the stock, MarketBeat Ratings reports. Nine research analysts have rated the stock with a hold rating. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $180.40.

Several analysts have issued reports on the stock. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Raymond James Financial cut Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Finally, Wells Fargo & Company upgraded Masimo to a “hold” rating in a research report on Wednesday, March 18th.

Get Masimo alerts:

Get Our Latest Report on MASI

Institutional Trading of Masimo

Several large investors have recently modified their holdings of MASI. Massachusetts Financial Services Co. MA increased its position in Masimo by 1.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock valued at $346,464,000 after purchasing an additional 43,915 shares during the period. T. Rowe Price Investment Management Inc. raised its stake in Masimo by 9.6% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock worth $303,061,000 after buying an additional 203,395 shares in the last quarter. Naya Capital Management UK Ltd. purchased a new stake in Masimo in the fourth quarter worth about $202,984,000. Westfield Capital Management Co. LP boosted its position in Masimo by 7.2% during the 4th quarter. Westfield Capital Management Co. LP now owns 1,522,049 shares of the medical equipment provider’s stock valued at $197,958,000 after acquiring an additional 102,799 shares in the last quarter. Finally, State Street Corp boosted its position in Masimo by 0.7% during the 2nd quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock valued at $250,041,000 after acquiring an additional 10,403 shares in the last quarter. 85.96% of the stock is owned by institutional investors.

Masimo Stock Performance

NASDAQ:MASI opened at $179.95 on Friday. The company has a market capitalization of $9.42 billion, a price-to-earnings ratio of -17.07, a PEG ratio of 1.82 and a beta of 1.11. The business has a 50 day moving average of $179.20 and a 200 day moving average of $165.36. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45. Masimo has a 1-year low of $125.94 and a 1-year high of $179.99.

Masimo Company Profile

(Get Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Featured Articles

• Five stocks we like better than Masimo
• Apple and Broadcom Forge a Decade-Long Silicon Fortress
• SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
• The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
• Palantir’s CEO Just Called Out OpenAI and Anthropic

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.